Spectrofluorimetric determination of itraconazole in dosage forms and spiked human plasma

Journal of the Chinese Chemical Society

Volumn 54, Issue 2, 2007, Pages 375-382

  El Enany, N ^a   El Sherbiny, D ^b   Belala, F ^a  

^a University of Mansoura   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Biological fluids; Itraconazole; Pharmaceutical preparation; Spectrofluorimetry

Indexed keywords

EID: 34548632067     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.200700054     Document Type: Article

References (29)

1. Hay, R.-J.; Dupont, B.; Graybill, J.-R. Rev. Infect. Dis. 1987, 9(Suppl. 1), S1-3.
2. Saag, M.-S.; Dismukes, W.-E. Antimicrob. Agents Chemother. 1988, 32, 1.
3. Zimmermann, T.; Yeates, R.-A.; Laufen, H. Eur. J. Clin. Pharmacol. 1994, 46, 147.
4. Haria, M.; Bryson, H.-M.; Goa, K.-L. Drugs 1996, 51, 585-620.
5. European Pharmacopoeia, The Council of Europe, Strasbourg: France, 4th Ed., 2005; pp 1852-1853.
6. Badock, N.-R. J. Chromatogr. B 1990, 525, 478.
7. Brandsteterova, E.; Kubalec, P.; Rady, A.; Krcmery, V. Pharmazie 1995, 50, 597.
8. Kubalec, P.; Brandsteterova, E. Pharmazie 2001, 56, 397.
9. Al-Rawithi, S.; Hussein, R.; Al-Moshen, I.; Raines, D. Ther. Drug Monit. 2001, 23, 445.
10. Allenmark, S.; Edebo, A.; Lindgren, K. J. Chromatogr. B 1990, 532, 203.
11. Compas, D.; Touw, D.-J.; de Goede, P. J. Chromatogr. B 1996, 687, 453.
12. Cox, S.; Orosz, S.; Burnette, J.; Frazier, D. J. Chromatogr. B 1997, 702, 175.
13. Gubbins, P.; Gurley, B.; Bowman, J. J. Pharm. Biomed. Anal. 1998, 16, 1005.
14. Ohkubo, T.; Osanai, T. Annals of Clinical Biochemistry 2005, 42, 94.
15. Poirier, J.-M.; Lebot, M.; Descamps, P.; Levy, M.; Cheymol, G. Ther. Drug Monit. 1994, 16, 596.
16. Poirier, J.-M. Ther. Drug Monit. 1997, 19, 247.
17. Rifai, N.; Sakamoto, M.; Platt, O.; Brugnara, C. Ther. Drug Monit. 1995, 17, 522.
18. Srivatsan, V.; Dasgupta, A.; Kale, P.; Datla, R.-R.; Soni, D.; Patel, M.; Patel, R.; Mavadhiya, C. J. Chromatogr. A 2004, 1031, 307.
19. Stefanie, R.; Bruce, G.-C. J. Biomed. Chromatogr. 2006 (In press).
20. Wang, J. W.; Ur-Rahman, N.; Yuen, K.-H. J. Chromatogr. B 2003, 798, 355.
21. Vogeser, M.; Sp?hrer, U.; Schiel, X. Clin. Chem. Lab. Med. 2003, 41, 915.
22. Yao, M.; Chen, L.; Srinivas, N.-R. J. Chromatogr. B 2001, 752, 9.
23. Carrier, A.; Parent, J. J. Chromatogr. B 2000, 745, 413.
24. Jimidar, M.-I.; Van Ael, W.; Shan, R.; Redlich, D.; de Smet, M. J. Capillary Electrophor. Microchip Technol. 2003, 8, 101.
25. Breadmore, M.-C.; Thormann, W. Electrophoresis 2003, 24, 2588.
26. Guidance for Industry; Q2B of Analytical Procedures: Methodology; International Conference on Hormonization (ICH), November 1996. http://www.fda.gov/eder/guidance/1320fnl.pdf (accessed September 1, 2004).
27. Guidance for Industry Bioanalytical method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, May. 2001. http://www.fda.gov/eder/ guidance/4252fnl.pdf (accessed September 1, 2004).
28. Miller, J. C.; Miller, J. N. Statistics for Analytical Chemistry; Wiley: New York, 1993, p 115.
29. rd Edition Pharmaceutical Press: USA, 2004; p 1151.